Financials

News Discussions Technicals Forecast Seasonals

0QLQ fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to YPSOMED HOLDING AG CHF14.15 (REGD) operating, investing, and financing activities

0QLQ free cash flow for H1 24 is -31.64 M CHF. For 2023, 0QLQ free cash flow was 46.85 M CHF and operating cash flow was 163.22 M CHF.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: CHF

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—